Previous results reported from the phase III MEASURE 2 study showed that secukinumab provided sustained improvement in signs and symptoms of ankylosing spondylitis (AS) over two years.
Biologic disease-modifying antirheumatic drugs (DMARDs) have significantly improved outcomes for patients with psoriatic arthritis (PsA).
On Monday at the 2017 annual meeting of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP), a team of researchers proposed using a bone health team to remotely screen, monitor, and treat veterans at risk for fragility fractures.
Patients with rheumatoid arthritis have many more treatment options thanks to recent advances, but patients’ health and well-being also requires self-management, such as lifestyle modifications to manage symptoms.
Researchers in China have developed a new online consultation tool for patients with rheumatic disease, which they hope will strengthen interactions between doctors and patients and lead to more efficient management of chronic illness. Their work was highlighted on Monday at the 2017 annual meeting of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP).